Identification of Biomarkers Based on Bioinformatics Analysis: The Expression of Ubiquitin-Conjugating Enzyme E2T (UBE2T) in the Carcinogenesis and Progression of Hepatocellular Carcinoma

Xuemiao Zhao; Wei Weng; Miao Jin; Sunjian Li; Qingwei Chen; Bingrong Li; Zhou Zhou; Chuanqiang Lan; Yunjun Yang

doi:10.12659/MSM.929023

04 March 2021 : Database Analysis

Identification of Biomarkers Based on Bioinformatics Analysis: The Expression of Ubiquitin-Conjugating Enzyme E2T (UBE2T) in the Carcinogenesis and Progression of Hepatocellular Carcinoma

Xuemiao Zhao^1ABEF, Wei Weng^2ACDE, Miao Jin^3CD, Sunjian Li^4AB, Qingwei Chen^5EF, Bingrong Li^2BC, Zhou Zhou^6BC, Chuanqiang Lan^2BE, Yunjun Yang^1AEF*

DOI: 10.12659/MSM.929023

Med Sci Monit 2021; 27:e929023

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 4 The survival analysis chart was drawn by the Kaplan-Meier plotter online tool; P<0.01 was considered statistically significant. (A) Overall survival curve analysis of key genes. (B) Progression-free survival curve analysis of UBE2T, CFP, and FBLN5. (C) Relapse-free survival curve analysis of UBE2T, CFP, and FBLN5.

Back to the Article

Identification of Biomarkers Based on Bioinformatics Analysis: The Expression of Ubiquitin-Conjugating Enzyme E2T (UBE2T) in the Carcinogenesis and Progression of Hepatocellular Carcinoma

Your Privacy